Provided by Tiger Trade Technology Pte. Ltd.

AMPLIFY WEIGHT LOSS DRUG & TREATMENT ETF

27.73
0.0000
Volume:395
Turnover:10.85K
Market Cap:5.55M
PE:- -
High:27.73
Open:27.73
Low:27.73
Close:27.73
52wk High:27.94
52wk Low:22.63
Shares:200.00K
Float Shares:200.00K
Volume Ratio:0.12
T/O Rate:0.20%
Dividend:0.41
Dividend Rate:1.49%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Novo Nordisk Completes Key Oral Semaglutide Study in Japan: What Investors Should Watch

TIPRANKS
·
Aug 14

Novo Nordisk’s SEMA-CardioDiab Hungary Study: What Real-World Oral Semaglutide Data Could Mean for NVO Investors

TIPRANKS
·
Aug 14

Novo Nordisk A/S Series B Stock Falls Thursday, Underperforms Market

Dow Jones
·
Aug 14

Scholar Rock Holding Price Target Raised to $63.00/Share from $56.00 by JP Morgan

Dow Jones
·
Aug 13

European Equities Traded in the US Rise in Thursday Trading

MT Newswires Live
·
Aug 13

Novo Nordisk CEO Defends Lawsuit Against Eli Lilly (LLY)

TIPRANKS
·
Aug 13

Novo CEO Says Obesity Market Won't be Winner-Take-All Battle with Lilly

Reuters
·
Aug 13

Berenberg Adjusts Price Target on Eli Lilly to $1,220 From $1,135, Maintains Hold Rating

MT Newswires Live
·
Aug 13

Eli Lilly : Berenberg Raises Target Price to $1220 from $1135

THOMSON REUTERS
·
Aug 13

Gamco Investors’ Mario Gabelli Ups Stake in Eli Lilly

TIPRANKS
·
Aug 13

Truist Financial Sticks to Their Buy Rating for Eli Lilly & Co (LLY)

TIPRANKS
·
Aug 13

Novo Nordisk CEO Defends Lawsuit Against Eli Lilly Over Weight-Loss Drug Ads

MT Newswires Live
·
Aug 13

Health Care Roundup: Market Talk

Dow Jones
·
Aug 13

Novo Nordisk (NVO) Stock Still Looks Cheap On Earnings But Faces Growth Doubts

Simply Wall St.
·
Aug 13

As Hims Prepares for Peptides Launch, Wall Street Cautious on Prospects This Year

Reuters
·
Aug 13

Novo Nordisk Might Need Deals to Strengthen Drug Pipeline

Dow Jones
·
Aug 13

Analysts Are Bullish on These Healthcare Stocks: TScan Therapeutics (TCRX), Eli Lilly & Co (LLY)

TIPRANKS
·
Aug 12

Eli Lilly (LLY) Sues Six Companies Over Weight-Loss Drug Sales

TIPRANKS
·
Aug 12

Eli Lilly is Suing Pharmacies and Peptide Vendors over Sales of the Next Big Weight-Loss Drug: Retatrutide

Dow Jones
·
Aug 12

Amplifica Holdings Group: Closes Oversubscribed $26 Mln Series B Preferred Stock Financing Led by Tasso Partners, Participation from Eli Lilly & Co

THOMSON REUTERS
·
Aug 12